About Enumeral

Enumeral is discovering and developing novel antibody immunotherapies that help the immune system attack diseased cells. We believe human-derived knowledge will better predict which antibody drug candidates are most likely to be effective in a targeted group of patients, with the goals of reducing side effects and accelerating the drug discovery and development process.

R&D

We study rare immune cells from human patients at high resolution and measure drug effects in a patient-specific, disease-specific manner. Harnessing The Power of Human™, our platform provides a basis for developing best-in-class product candidates from a fundamental understanding of how immunotherapies work in each patient.